Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Lactobacillus Plantarum and Hormonal Regulation in Obese Women

Lactobacillus Plantarum Lp90 and Hormonal Regulation in Obese Women:A Randomized, Double-Blind, Placebo-Controlled Trial

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Age: 18 to 40 years old, female, BMI ≥ 25 kg/m2. 2. Be willing to receive follow-up during the intervention period. 3. Be willing to provide two blood, urine and fecal samples during the intervention period. 4. Be willing to take the compound probiotics by oneself every day during the intervention period. 5. Have good hearing and be able to hear and understand all instructions during the intervention period. \- Who Should NOT Join This Trial: 1. Suffering from digestive system diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease). 2. Suffering from severe neurological disorders (epilepsy, stroke, severe head trauma, meningitis within the past 10 years, brain surgery, brain tumor, long-term coma - excluding general anesthesia). 3. Have received/are currently receiving treatment for the following mental illnesses: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder. 4. Take medication for depression or low mood. 5. Suffering from internal organ failure (such as heart, liver or kidney failure, etc.). 6. Have received radiotherapy or chemotherapy in the past. 7. Have received general anesthesia surgery/procedures within the past three years, or plan to receive general anesthesia procedures/surgeries within the next three months during this trial. 8. Have suffered from hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past. \- Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Age: 18 to 40 years old, female, BMI ≥ 25 kg/m2. 2. Be willing to receive follow-up during the intervention period. 3. Be willing to provide two blood, urine and fecal samples during the intervention period. 4. Be willing to take the compound probiotics by oneself every day during the intervention period. 5. Have good hearing and be able to hear and understand all instructions during the intervention period. \- Exclusion Criteria: 1. Suffering from digestive system diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease). 2. Suffering from severe neurological disorders (epilepsy, stroke, severe head trauma, meningitis within the past 10 years, brain surgery, brain tumor, long-term coma - excluding general anesthesia). 3. Have received/are currently receiving treatment for the following mental illnesses: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder. 4. Take medication for depression or low mood. 5. Suffering from internal organ failure (such as heart, liver or kidney failure, etc.). 6. Have received radiotherapy or chemotherapy in the past. 7. Have received general anesthesia surgery/procedures within the past three years, or plan to receive general anesthesia procedures/surgeries within the next three months during this trial. 8. Have suffered from hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past. \-

Treatments Being Tested

DIETARY_SUPPLEMENT

Probiotic

The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).

DIETARY_SUPPLEMENT

Maltodextrin

The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).

Locations (1)

Fuwai Central-China Cardiovascular Hospital
Zhengzhou, Henan, China